US 12343381
Dosage regimen for pegylated interferon
granted A61KA61K38/21A61K38/212
Quick answer
US patent 12343381 (Dosage regimen for pegylated interferon) held by PHARMAESSENTIA CORPORATION expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHARMAESSENTIA CORPORATION
- Grant date
- Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/21, A61K38/212, A61K47/60, A61P